Health
Research uncovers potential cause of neurotoxicity due to immunotherapy – News-Medical.Net
New research has uncovered the previously unknown presence of CD19 — a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma — in brain cells that protect the blood brain barrier (…

Reviewed by Emily Henderson, B.Sc.Sep 21 2020
New research has uncovered the previously unknown presence of CD19 — a B cell molecule targeted by chimeric antigen receptor (CAR) T cell immunotherapy to treat leukemia, lymphoma, and multiple myeloma — in brain cells that protect the blood brain barrier (BBB).
This discovery may potentially be the cause for neurotoxicity in patients undergoing CD19 directed CAR T cell immunotherapy, according to the research team led by Avery Posey, PhD, an ass…
-
Noosa News21 hours ago
Queensland’s bid for net zero by 2050 unlikely under new energy plan: expert
-
General22 hours ago
María Corina Machado awarded Nobel Peace Prize
-
General21 hours ago
Donald Trump didn’t receive the Nobel Peace Prize. Experts say he had ‘no chance’ at winning
-
General19 hours ago
Western Bulldogs extend Essendon’s losing streak with 57 point thrashing